UB Paderborn / Katalog / Suche / in CDI

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)

Annals of oncology, 2021-04, Vol.32 (4), p.533-541

2021

Volltextzugriff (PDF)

Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma

European journal of surgical oncology, 2010-05, Vol.36 (5), p.477-482

2010

Volltextzugriff (PDF)

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital

Annals of oncology, 2005-03, Vol.16 (3), p.437-444

2005

Volltextzugriff (PDF)

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 2002-03, Vol.38 (4), p.556-559

2002

Volltextzugriff (PDF)

Targeting protein kinase C in sarcoma

Biochimica et biophysica acta, 2014-12, Vol.1846 (2), p.547-559

2014

Volltextzugriff (PDF)

Potential role of phytoestrogens in the pathophysiology of fibromatosis

Annals of oncology, 2011-12, Vol.22 (12), p.2697-2698

2011

Volltextzugriff (PDF)

Radiofrequency ablation is a feasible therapeutic option in the multi modality management of bone and soft tissue sarcoma

European journal of surgical oncology, 2010-05, Vol.36 (5)

2010

Volltextzugriff (PDF)

Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics

European journal of cancer (1990), 2003-03, Vol.39 (4), p.532-540

2003

Volltextzugriff (PDF)

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma

European journal of cancer (1990), 2000-05, Vol.36 (7), p.881-888

2000

Volltextzugriff (PDF)

Increased tumour extracellular pH induced by Bafilomycin A 1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics

European journal of cancer (1990), 2003, Vol.39 (4), p.532-540

2003

Volltextzugriff (PDF)

73 POSTER Pharmacokinetic characterization of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in advanced cancer patients

European journal of cancer supplements, 2006-11, Vol.4 (12), p.26-26

2006

Volltextzugriff (PDF)

The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours

Annals of oncology, 1997-11, Vol.8 (11), p.1099-1105

1997

Volltextzugriff (PDF)

Synovial sarcoma: experience of 150 cases in 11 years

European journal of cancer (1990), 1999-09, Vol.35, p.S266-S266

1999

Volltextzugriff (PDF)

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

The Lancet (British edition), 1989-10, Vol.334 (8668), p.879-882

1989

Volltextzugriff (PDF)

In vitro and in vivo antitumor activity of benzyl isothiocyanate: a natural product from Tropaeolum majus

Planta medica, 1995-06, Vol.61 (3), p.233-236

1995

Volltextzugriff (PDF)

Pharmacokinetic modelling—A prelude to therapeutic drug monitoring for all cancer patients?

European journal of cancer (1990), 1995-10, Vol.31 (11), p.1733-1735

Judson, I.R.

1995

Volltextzugriff (PDF)

330 Magnetic resonance spectroscopy confirms the mechanism of action of the choline kinase inhibitor MN58b in human breast cancer cells

European journal of cancer supplements, 2004-09, Vol.2 (8), p.100-100

2004

Volltextzugriff (PDF)

346 Pharmacodynamic markers for the choline kinase inhibitor MN58b in human breast cancer model by magnetic resonance spectroscopy

European journal of cancer supplements, 2004-09, Vol.2 (8), p.105-105

2004

Volltextzugriff (PDF)

An Infrastructure of Network Services for Seamless Integration in Advanced Collaborative Computing Environments

2005 IEEE International Conference on Cluster Computing, 2005, p.1-10

2005

Volltextzugriff (PDF)

Letter to the editors

Cancer chemotherapy and pharmacology, 1987-10, Vol.20 (2)

1987

Volltextzugriff (PDF)

1199 Adult Ewing's sarcoma–the Royal Marsden experience

European journal of cancer (1990), 1995-11, Vol.31, p.S250-S250

1995

Volltextzugriff (PDF)

Introduction to building projection-based tiled display systems

IEEE computer graphics and applications, 2000-07, Vol.20 (4), p.22-28

2000

Volltextzugriff (PDF)

Prophesy: an infrastructure for analyzing and modeling the performance of parallel and distributed applications

High Performance Distributed Computing: Proceedings of the 9th IEEE International Symposium on High Performance Distributed Computing; 01-04 Aug. 2000, 2000, p.302-303

2000

Volltextzugriff (PDF)

The development of the new anticancer drug trimelamol

Judson, I.R

1989

Volltextzugriff (PDF)

A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy

European journal of cancer (1990), 1997-12, Vol.33 (14), p.2418-2427

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Targeting protein kinase C in sarcoma

Potential role of phytoestrogens in the pathophysiology of fibromatosis

Radiofrequency ablation is a feasible therapeutic option in the multi modality management of bone and soft tissue sarcoma

Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma

Increased tumour extracellular pH induced by Bafilomycin A 1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokinetics

73 POSTER Pharmacokinetic characterization of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in advanced cancer patients

The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours

Synovial sarcoma: experience of 150 cases in 11 years

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

In vitro and in vivo antitumor activity of benzyl isothiocyanate: a natural product from Tropaeolum majus

Pharmacokinetic modelling—A prelude to therapeutic drug monitoring for all cancer patients?

330 Magnetic resonance spectroscopy confirms the mechanism of action of the choline kinase inhibitor MN58b in human breast cancer cells

346 Pharmacodynamic markers for the choline kinase inhibitor MN58b in human breast cancer model by magnetic resonance spectroscopy

An Infrastructure of Network Services for Seamless Integration in Advanced Collaborative Computing Environments

Letter to the editors

1199 Adult Ewing's sarcoma–the Royal Marsden experience

Introduction to building projection-based tiled display systems

Prophesy: an infrastructure for analyzing and modeling the performance of parallel and distributed applications

The development of the new anticancer drug trimelamol

A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy

Suchergebnisse filtern